262 results on '"Gartner, Jared J"'
Search Results
2. Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
3. Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
4. A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types
5. mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
6. Recognition of human gastrointestinal cancer neoantigens by circulating PD-[1.sup.+] lymphocytes
7. Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities
8. Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
9. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma
10. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
11. Cell surface marker-based capture of neoantigen-reactive CD8+T-cell receptors from metastatic tumor digests
12. Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
13. Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers
14. Supplementary Figures from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
15. Supplementary Table 4 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
16. Supplementary Data from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
17. Supplementary Figure from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
18. Supplementary Figure 5 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
19. Supplementary Table 3 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
20. Supplementary Tables 1 and 2 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
21. Data from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
22. Data from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
23. Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
24. Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
25. Supplementary Figures from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
26. Supplementary Table 1 from Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
27. Supplementary Figure 1 from Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
28. Data from Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
29. Supplementary Figures S1-S15 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
30. Supplementary Data S3 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
31. Specific recognition of anFGFR2fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma
32. Data from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
33. Table S1 and S2 from T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
34. Supplementary Table from Neoantigen Identification and Response to Adoptive Cell Transfer in Anti–PD-1 Naïve and Experienced Patients with Metastatic Melanoma
35. Supplemental Figure 2 from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
36. Supplemental Table 1 from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
37. Supplemental Figure 1 from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
38. Materials and Methods and Figures S1-S6 from T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
39. Supplemental Figure 3 from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
40. Supplemental Table 2 from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
41. Supplemental Table 3 from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
42. Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
43. Immunogenicity of somatic mutations in human gastrointestinal cancers
44. Immunogenicity of non-canonical HLA-I tumor ligands identified through proteogenomics
45. Genetic and Functional Analysis of GRIN2A in Tumor Samples
46. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
47. Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
48. Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes
49. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers
50. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.